European Institute of Science AB Logo

European Institute of Science AB

Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.

EURI B | SPGR

Overview

Corporate Details

ISIN(s):
SE0020357440 (+1 more)
LEI:
549300VADF7E2RMTRE02
Country:
Sweden
Address:
Ideongatan 1A, 223 70 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

European Institute of Science AB is a manufacturer of diagnostic assays and point-of-care (POC) instrumentation, with a primary focus on the veterinary health market. The company develops, produces, and sells solutions for canine, feline, and equine diagnostics, targeting veterinary professionals in clinical laboratories and POC settings. Key products include the TurboReader™, a compact nephelometric diagnostic reader, and a portfolio of rapid in-vitro assays for monitoring inflammation and other health conditions. The company also distributes third-party veterinary products in Scandinavia. Founded in 1990, it has a history as a research and development hub that has successfully spun off multiple public med-tech and biotech companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-10-03 20:01
Major Shareholding Notification
English 33.4 KB
2009-02-11 11:09
Annual / Quarterly Financial Statement
Swedish 323.6 KB
2009-02-02 14:29
Delisting Announcement
Swedish 255.8 KB
2008-10-31 09:45
Quarterly Report
Swedish 328.3 KB
2008-09-30 13:47
Regulatory News Service
Swedish 28.4 KB
2008-08-29 10:36
Interim Report
Swedish 322.1 KB
2008-06-30 08:05
Regulatory News Service
Swedish 259.1 KB
2008-05-16 15:08
Post-Annual General Meeting Information
Swedish 258.5 KB
2008-04-29 00:00
Annual Report
Swedish 687.0 KB
2008-04-18 12:45
Pre-Annual General Meeting Information
Swedish 45.8 KB
2008-04-14 09:22
Quarterly Report
Swedish 320.2 KB
2008-01-21 10:46
Earnings Release
Swedish 320.6 KB
2007-10-26 08:14
Quarterly Report
Swedish 322.1 KB
2007-10-16 10:47
Earnings Release
Swedish 257.6 KB
2007-08-31 11:52
Interim Report
Swedish 320.1 KB

Automate Your Workflow. Get a real-time feed of all European Institute of Science AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for European Institute of Science AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-27 Pharmart AB Other Sell 9,341 19,709.51 SEK

Peer Companies

Company Country Ticker View
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.